Mahindra Lifespace Developers (532313) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
8 May, 2026Executive summary
Achieved record Q4 residential pre-sales of ₹1,633 Cr and FY26 pre-sales of ₹3,405 Cr, with 25% YoY growth in consolidated sales to ₹4,118 Cr.
PAT surged to ₹298 Cr in FY26, nearly 5x growth over FY25, driven by higher share of profits from joint ventures and associates.
Strategic partnership with Mitsui Fudosan closed for the Blossom project, enhancing capital infusion and business development.
Significant GDV additions, crossing ₹45,180 Cr, with a healthy launch pipeline and approvals for major projects.
Strong leasing activity in Jaipur and Chennai, with healthy realization and ongoing land aggregation.
Financial highlights
Combined residential and IC pre-sales reached ₹4,120 Cr for FY26.
FY26 consolidated PAT: ₹298 Cr (vs. ₹61 Cr FY25); net debt-to-equity improved to -0.27 (from 0.39).
Operating cash flow for FY26 was ₹840 Cr, after accounting for approval costs for Mahindra Rainforest.
Net cash balance at group level stood at ₹1,127 Cr against gross debt of ₹383 Cr.
Equity net worth increased to ₹3,62,687 lakhs, aided by a rights issue and profit consolidation.
Outlook and guidance
Pre-sales guidance for FY27 is ₹4,500–5,000 Cr for residential, with industrial sales on top.
Launch pipeline for FY27 is around ₹10,000 Cr, with Rainforest contributing ₹3,000 Cr.
Business development target for FY27 is north of ₹10,000 Cr, with a 60/20/20 split across Mumbai, Pune, and Bangalore.
Multi-year growth visibility with cumulative GDV of ~₹45,180 Cr.
Management continues to monitor regulatory changes, especially new Labour Codes, for future financial impact.
Latest events from Mahindra Lifespace Developers
- Q1 pre-sales tripled, net profit rebounded, and leverage improved amid strong project momentum.532313
Q1 24/254 Feb 2026 - Strong Q3 sales, robust pipeline, and improved profitability with net debt/equity at -0.12.532313
Q3 25/262 Feb 2026 - Strong H1 FY25 growth, robust pipeline, and ambitious 2028 sales target.532313
Q2 24/2520 Dec 2025 - Strong H1 FY26 growth, profit turnaround, and robust GDV pipeline support future momentum.532313
Q2 25/2619 Dec 2025 - Strong GDV growth and sales drive expansion, with execution and capital discipline in focus.532313
Q3 24/2518 Dec 2025 - Record GDV, premium focus, and rights issue drive growth; ₹2.80 dividend proposed.532313
Q4 24/2517 Dec 2025 - Strong GDV growth, improved leverage, and premium focus drive a positive outlook.532313
Q1 25/2616 Dec 2025